NEW YORK (GenomeWeb News) – Signature Genomics Laboratories has received its New York Clinical Laboratory Permit, allowing the firm to receive specimens drawn by clinical laboratories in the state of New York for testing.
The Spokane, Wash.-based firm said today that it is the first laboratory to receive a New York permit to perform microarray-based comparative genomic hybridization. It uses the technology, called SignatureChip, for the genetic evaluation of individuals with unexplained mental retardation and birth defects.
The firm noted that the New York State Clinical Laboratory Permit is issued annually. Signature also holds licenses as an out-of-state clinical lab in Rhode Island, Florida, and California.